HomeFile

File

View Category
Antithrombotic Anticoagulants

Atrial Fibrillation and Dementia: Which Anticoagulant Agent Presents the Lowest Risk?

Atrial fibrillation is a risk factor for dementia and anticoagulant agents have been proven to decrease it....
solaci -
Learn More
Antithrombotic Anticoagulants

AFIRE Trial: Atrial Fibrillation and PCI. What is the Ideal Therapy?

Patients with atrial fibrillation undergoing percutaneous coronary intervention (PCI) will benefit from rivaroxaban monotherapy both in terms...
solaci -
Learn More
Structural heart disease

Is Troponin Elevation After TAVR Related to Mortality?

Troponins have long had diagnostic value not only for infarction. Their ability to predict mortality is well...
solaci -
Learn More
Acute coronary syndromes

First Guidelines Focused Specifically on Chest Pain Management

Many years of developing and waiting have led us to the latest guidelines published by ACC/AHA together...
solaci -
Learn More
Chronic Ischemic cardiopathy

ISCHEMIA: Prognosis is Determined by Anatomy, not Functionality

The ISCHEMIA study keeps providing scientific news. This work in patients with stable coronary artery disease had...
solaci -
Learn More
Peripheral vascular disease

Fluoroscopy vs. Ultrasound Guided Femoral Access in TAVR

Ideally, we will not puncture the femoral artery blindly if we are planning to use a big...
solaci -
Learn More
Bifurcations

10 Years Treating Bifurcations: Have We Made Progress?

Bifurcations have been, are and will be challenging. However, we have to admit we have gained experience...
solaci -
Learn More
Structural heart disease

Device Evolution Also Impacts on Valve in Valve

TAVR to treat dysfunctional biological prosthetics (ViV) with the last generation self-expandable supra-annular prosthetic offers excellent results...
solaci -
Learn More